Loading…
Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics
Peptidomimetic motilin antagonists ( 17c and 17d) were identified. Both compounds dose-dependently suppressed motilin-induced colonic and gastric motility in conscious dogs. We successfully discovered peptidomimetic motilin antagonists ( 17c and 17d) through the improvement of physicochemical proper...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2009-07, Vol.19 (13), p.3426-3429 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Peptidomimetic motilin antagonists (
17c and
17d) were identified. Both compounds dose-dependently suppressed motilin-induced colonic and gastric motility in conscious dogs.
We successfully discovered peptidomimetic motilin antagonists (
17c and
17d) through the improvement of physicochemical properties of a tetrapeptide antagonist (
2). Furthermore, with oral administration and based on motilin antagonistic activity, both compounds suppressed motilin-induced colonic and gastric motility in conscious dogs. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.05.059 |